News
-
Call for greater medicine affordability
Tuesday | Feb 18 2025AS PATIENTS struggle to pay for their medicine, the Pharmacy Guild of Australia has urged the Government to act to make medicines more affordable.
-
Wegovy gets TGA approval for CVD
Tuesday | Feb 18 2025THE Therapeutic Goods Administration (TGA) has approved Wegovy 2.4mg (semaglutide) to be used as a complementary therapy for reducing major adverse cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction (heart attack), or non-fatal stroke.
-
Australian Prescriber marks 50 years
Tuesday | Feb 18 2025AUSTRALIAN Prescriber is celebrating its 50 year anniversary this year, thanking its 100,000 plus healthcare subscribers for their continued support over the years.
-
APP2025 top tip
Tuesday | Feb 18 2025AMONG the Chairman's Top 20 sessions for APP2025 is 'Digital Health: The next 5 years for pharmacy', on the afternoon of Thu 20 Mar.
-
Hundreds take up free meningococcal B vax
Tuesday | Feb 18 2025ALMOST 1,300 eligible young people in the Northern Territory have received the free Meningococcal B vaccine since the program launched on 01 Jan, announced Steve Edgington, NT Minister for Health.
-
Mobile education for rural HPs
Tuesday | Feb 18 2025PFIZER Australia has announced a partnership with Heart of Australia (HoA) mobile health service, to expand its GP Education Program with the aim of improving healthcare delivery in rural and remote parts of Australia.
-
Guild Pharmacy of the Year finalists announced
Monday | Feb 17 2025THE Guild has announced the five finalists for the Guild Pharmacy of the Year 2025 Award, celebrating the outstanding contribution of pharmacies across the country.
-
MCRI to deliver kids program
Monday | Feb 17 2025MURDOCH Children's Research Institute (MCRI) in Melbourne has partnered with Independent Pharmacies Australia (IPA), Pharma Programs and Prax Hub to launch their first online accredited pharmacy training program focused on children's health.
-
Equity challenges in obesity
Monday | Feb 17 2025THE use of glucagonlike peptide1 receptor agonists (GLP1 RAs) for the treatment of obesity has the potential to impact onethird of Australians, with implications for funding and models of care to ensure equitable access, wrote experts in the Medical Journal of Australia.
-
WA Labor pledges ADHD role for GPs
Monday | Feb 17 2025SPECIALIST GPs will be able to diagnose attention deficit hyperactivity disorder (ADHD) and initiate and manage its treatment with stimulant medication under proposed WA Labor reforms.
